The protein C330013F16Rik is a pivotal player in cellular processes, assuming a critical role in signal transduction pathways that orchestrate diverse cellular functions. This protein intricately navigates signaling cascades, specifically those associated with MAPK, PI3K/Akt, JAK/STAT, NF-κB, RAS/MAPK, Wnt/β-catenin, TGF-β, Notch, Hedgehog, mTOR, and AMPK pathways. C330013F16Rik functions as a central signaling node, exerting influence on downstream events that intricately modulate gene expression, cellular proliferation, differentiation, and survival. In dissecting the general mechanisms of inhibiting C330013F16Rik, a comprehensive understanding emerges by focusing on the interconnected signaling pathways mentioned earlier. Chemical inhibitors identified in this context exert their effects by targeting specific components within these intricate pathways, inducing altered expression patterns of proteins integral to the regulatory network of C330013F16Rik. Take, for example, Trametinib, a potent inhibitor that directly impacts C330013F16Rik by influencing critical components of the MAPK pathway. By suppressing SPRY4, a negative feedback regulator within this pathway, Trametinib effectively leads to the inhibition of C330013F16Rik.
The significance of unraveling these intricate interactions lies in the valuable insights it provides for devising potential strategies to manipulate the function of C330013F16Rik in various cellular contexts. The identified chemical inhibitors serve as powerful tools to dissect the signaling pathways associated with C330013F16Rik, offering a nuanced understanding of its regulatory network. This knowledge not only sheds light on the fundamental biology of cellular processes but also opens avenues for targeted interventions in diseases where dysregulation of C330013F16Rik may play a contributory role. Furthermore, the intricate interplay of C330013F16Rik with multiple signaling pathways underscores its versatility and importance in cellular homeostasis. The protein's involvement in diverse pathways highlights its potential as a key regulator with far-reaching implications. As researchers delve deeper into the molecular intricacies of C330013F16Rik and its interactions with chemical inhibitors, the groundwork is laid for uncovering novel approaches and refining our understanding of the intricate web of cellular signaling that orchestrates fundamental biological processes.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Inhibits C330013F16Rik by targeting the MAPK pathway. Suppresses SPRY4, a negative feedback regulator, leading to protein inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Targets PI3K/Akt pathway, modulating PTEN expression. Alters downstream signals affecting C330013F16Rik and inducing inhibition. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Disrupts JAK/STAT pathway, influencing SOCS expression. Results in indirect inhibition of C330013F16Rik through pathway modulation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits C330013F16Rik by impacting the NF-κB signaling pathway. Alters the expression of associated proteins, leading to inhibition. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Targets RAS/MAPK pathway, affecting the expression of upstream regulators. Induces inhibition of C330013F16Rik through pathway interference. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Modulates Wnt/β-catenin pathway, indirectly inhibiting C330013F16Rik. Alters the expression of pathway components leading to inhibition. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Influences TGF-β signaling, affecting Smad proteins. Induces indirect inhibition of C330013F16Rik through modulation of the signaling cascade. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Targets Notch signaling pathway, influencing HES expression. Results in indirect inhibition of C330013F16Rik through pathway interference. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Inhibits C330013F16Rik by impacting the Hedgehog pathway. Alters the expression of associated proteins, leading to inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Modulates mTOR pathway, indirectly inhibiting C330013F16Rik. Alters the expression of pathway components leading to inhibition. | ||||||